Condom is “Alzheimer’s helping city”

In the preamble to the film “Une Vie démente” directed by Ann Siro and Raphaël Balboni and screened at Le Gascogne cinema, Mayor Jean-François Rousse and Jean-Marc Pinaud, president of the France Alzheimer association in Gers, signed the charter of reciprocal commitments “City helping Alzheimer”. Also present were Monique Gensac, volunteer referent of the Condom … Read more

Le groupe Menarini partage de nouvelles analyses de l’étude clinique EMERALD d’ORSERDU® (élacestrant) dans le cancer du sein métastatique à l’ASCO 2023 USA – English USA – Deutsch Latin America – español France – Français Brazil – Português

·  ORSERDU (élacestrant) a été approuvé par la FDA en janvier 2023 pour le traitement du cancer du sein avancé ou métastatique à récepteurs d’œstrogènes (ER) positifs et à récepteurs 2 du facteur de croissance épidermique humain (HER2) négatifs avec des mutations ESR1 (ESR1-mut) qui se trouvent dans jusqu’à 40 % des tumeurs ·  Chez les patientes dont … Read more

Dr. Kieran Murphy Presents Results of Clinical Trial Demonstrating Positive Effect Protecting DNA From Radiation Exposure

TORONTO, May 27, 2023 /PRNewswire/ – Cora Therapeutics, a dynamic life sciences startup based in Toronto, proudly unveils the results of a clinical trial at the Canadian Association of Interventional Radiologists (CAIR) annual meeting in Quebec City. Dr. Kieran Murphy MD, FRCPC, FSIR, Founder, Inventor, and CMO of Cora Therapeutics, announced the efficacy of a proprietary … Read more

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Chinook To Contact Him Directly To Discuss Their Options

NEW YORK, May 27, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Chinook Therapeutics, Inc. (“Chinook” or the “Company”) (NASDAQ: KDNY). If you suffered losses exceeding $50,000 investing in Chinook stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner … Read more

En el marco de la ASCO 2023, Menarini Group comparte su nuevo análisis del estudio clínico EMERALD de ORSERDU® (Elacestrant) para el cáncer de mama metastásico Latin America – español USA – English USA – English USA – Deutsch Brazil – Português

ORSERDU (elacestrant) fue aprobado por la Administración de Alimentos y Medicamentos (FDA) en enero de 2023 para el cáncer de mama avanzado o metastásico positivo al receptor de estrógeno (ER) y negativo al factor de crecimiento epidérmico humano 2 (HER2) con mutaciones en ESR1 (ESR1 -mut) que se encuentran en hasta el 40 % de … Read more

“Endocrine disruptors play the role of imposter” according to Toulouse researcher Nicolas Cabaton

the essential Raise citizens’ awareness of the challenges of endocrine disruptors and the best practices to adopt. These are the objectives of Toulouse Métropole, which is organizing three workshops on the subject. The Toulouse researcher Nicolas Cabaton who officiates at INRAE ​​will bring his knowledge on June 1st. Could you explain what an endocrine disruptor … Read more

Condom. Alzheimer’s: a film and a charter to inform and act

the essential Condom has become a “helping city”. Information to the public, professionals mobilized: means to help families and patients. As part of an awareness campaign for the general public, the France Alzheimer and Related Diseases Association (FAMA) organized a screening at the “Le Gascogne” cinema. On the screen, in the presence of about sixty … Read more